Upcoming webinars

We invite you to watch our free webinar with Far East Gold, featuring Chairman Paul Walker. Paul will be holding an investor briefing to outline the company’s diversified pipeline of six copper and gold projects. 

Far East Gold (ASX:FEG) is an Australian junior exploration company led by some of the biggest names in Australian mining. The company has secured the commercial rights for the acquisition, exploration and development of six advanced gold and copper projects in Indonesia and Australia. Phase 2 drilling is underway at their flagship Woyla copper gold project, following bonanza-grade assay results of up to 119g/t gold and 1,179g/t silver.

 

Paul will detail progress at the Woyla project - one of the most highly prospective undrilled copper gold projects in South-East Asia with the potential to host high grade epithermal and porphyry deposits.

 

Register your details on Far East Gold’s investor portal to stay up to date with news and announcements: https://fareastgold.investorportal.com.au/register/

The webinar will include a live Q&A, providing you the opportunity to ask Paul any questions about FEG that you may have. Registrants may send in questions beforehand if they prefer to enquiries@portjacksonsecurities.com.

We invite you to watch our free webinar with Prescient Therapeutics, featuring Prescient CEO and MD Steven Yatomi-Clarke. Steven will be holding a webinar to outline the company’s diversified portfolio of later stage and emerging assets for cancer treatment.

Prescient Therapeutics (ASX: PTX) is emerging as a key player of the cell therapy revolution, featuring a broad portfolio of well-advanced assets developed with world-leading partners, including Yale, UPenn, Oxford University and Peter MacCallum.

 

Prescient’s world-class portfolio boasts a diversified range of assets with two first-in class targeted therapies, PTX-100 and PTX-200, that are currently in clinical development and showing encouraging activity in diseases of unmet need. Prescient owns the exclusive rights to two vital CAR-T platform technologies, OmniCAR and CellPryme – both with the potential to elevate and enhance CAR-T therapies – effectively giving them a ‘shovels to the gold rush’ advantage in a burgeoning area of cancer treatment.

 

The webinar will include a live Q&A, providing you the opportunity to ask Steven any questions about PTX that you may have. Registrants may send in questions beforehand if they prefer to enquiries@portjacksonsecurities.com.

We invite you to watch our free webinar with Service Stream, featuring Managing Director Leigh Mackender and Chief Financial Officer Linda Kow.

Leigh and Linda will give us a presentation with the latest updates on Service Stream.

The webinar will include a live Q&A, providing you the opportunity to ask Leigh and Linda any questions about SSM that you may have. Registrants may send in questions beforehand if they prefer to enquiries@portjacksonsecurities.com.

We invite you to watch our free webinar with Renergen, featuring CEO Stefano Marani.

Stefano will give us an update on RLT. 

The webinar will include a live Q&A, providing you the opportunity to ask Stefano any questions about RLT that you may have. Registrants may send in questions beforehand if they prefer to enquiries@portjacksonsecurities.com.

We invite you to watch our free webinar with Barton Gold, featuring Managing Director and CEO Alexander Scanlon.

Alexander will discuss BGD's first MRE update for the year, and take us through exploration results. 

The webinar will include a live Q&A, providing you the opportunity to ask Alexander any questions about BGD that you may have. Registrants may send in questions beforehand if they prefer to enquiries@portjacksonsecurities.com.